New York Files Charges Against Johnson & Johnson Over Opioid Marketing

New York's Department of Financial Services filed civil charges against Johnson & Johnson (NYSE:JNJ) on Thursday, accusing the biopharmaceutical giant of downplaying the risks to patients associated with the use of prescription opioids.